| Net income | 2.1M |
| Depreciation and amortization | 327.63K |
| Amortization of deferred gain on sale/leaseback | |
| Amortization of deferred income from grant | |
| Interest added to certificate of deposit | |
| Share-based compensation | 364.7K |
| Changes in operating assets and liabilities | |
| Net cash provided by operating activities | |
| (Increase) decrease in restricted cash | |
| Capital expenditures | -3.43K |
| Net cash used in investing activities | |
| Proceeds from exercise of stock options | |
| Proceeds from exercise of warrants | |
| Taxes paid in lieu of shares | |
| Purchases of common stock for treasury shares | 0 |
| Dividends paid on common stock | 0 |
| Payments on capital lease obligations | |
| Net cash used in financing activities | |
| Net increase in cash | -895.13K |
| Cash at beginning of period | |
| CASH AT END OF PERIOD | |
| Income taxes paid | |
| Reduction of accrued expense upon issuance of shares | |
| Dividends declared (unpaid dividend on restricted stock) | |